Skip to main content
. 2008 Jan 3;466(3):729–736. doi: 10.1007/s11999-007-0051-0

Fig. 4.

Fig. 4

A Kaplan–Meier curve of overall survival based on absence or presence of gefitinib treatment is illustrated. The dotted lines indicate the 95% confidence interval. The mean survival is longer (p = 0.005) in the group treated with gefitinib than in the untreated group among 52 patients with adenocarcinoma and PS 1 or less.